BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6324419)

  • 1. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
    Harney BA; Easty DL; Skinner GR
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultivation of ganglia on monofil fabric, a suitable method for demonstration of latent herpesvirus infection.
    Benda R; Cinátl J; Petrovic S; Roubal J; Plaisner V
    Acta Virol; 1973 Jul; 17(4):305-9. PubMed ID: 4148210
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.
    Laycock KA; Lee SF; Brady RH; Pepose JS
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2741-6. PubMed ID: 1654309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term therapeutic effect of an inactivated herpes simplex virus type 1 vaccine on herpes simplex keratitis].
    Zhang YQ
    Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):339-42. PubMed ID: 6327206
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
    Carter CA; Hartley CE; Skinner GR; Turner SP; Easty DL
    Br J Ophthalmol; 1981 Oct; 65(10):679-82. PubMed ID: 6274376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular herpes simplex and the establishment of latent infection.
    Tullo AB; Easty DL; Hill TJ; Blyth WA
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():15-8. PubMed ID: 6301114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histology of the eye after zosteriform spread of herpes simplex virus in the mouse.
    Claoue C; Hodges T; Hill T; Blyth W; Easty D
    Br J Exp Pathol; 1987 Aug; 68(4):585-93. PubMed ID: 2820460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental pathogenesis of non-lethal herpesvirus infection and the establishment of latency.
    Rajcáni J; Ciampor F
    Acta Virol; 1978 Jul; 22(4):278-86. PubMed ID: 29466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron microscopic localization of herpes simplex virus antigens in rabbit cornea with antihuman IgG-antiferritin hybrid antibodies.
    Metcalf JF; Helmsen R
    Invest Ophthalmol Vis Sci; 1977 Sep; 16(9):779-86. PubMed ID: 197043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against herpetic ocular disease in an outbred mouse model.
    Metcalf JF; Whitley RJ
    Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from experimental ocular herpetic keratitis by a heat-killed virus vaccine.
    Metcalf JF
    Arch Ophthalmol; 1980 May; 98(5):893-6. PubMed ID: 6246863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection.
    Nesburn AB; Cook ML; Stevens JG
    Arch Ophthalmol; 1972 Oct; 88(4):412-7. PubMed ID: 4342439
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody and cell-mediated immunity to a DNA free herpes simplex subunit vaccine.
    Cappel R; de Cuyper F; de Braekeleer J
    Dev Biol Stand; 1979; 43():381-5. PubMed ID: 230114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
    J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis.
    Tullo AB; Easty DL; Shimeld C; Stirling PE; Darville JM
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():159-65. PubMed ID: 2986322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis.
    Meyers-Elliott RH; Chitjian PA; Billups CB
    Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1170-80. PubMed ID: 3036742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.